| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash flows from financing activities | -104,221 | -93,731 |
| Net decrease in cash, cash equivalents and restricted cash | -10,244 | -30,431 |
| Cash and cash equivalents at beginning of period | 83,433 | - |
| Cash and cash equivalents at end of period | 73,189 | - |
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)